Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences

• Published in: Genes Vol. 14; no. 10; p. 1927
• Main Authors: Finotti, Alessia, Gasparello, Jessica, Zuccato, Cristina, Cosenza, Lucia Carmela, Fabbri, Enrica, Bianchi, Nicoletta, Gambari, Roberto
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.10.2023; MDPI
• Subjects: Analysis; Antitumor agents; BCL11A; beta-Thalassemia - genetics; Blood diseases; Cells; Cloning; CRISPR; Erythroid cells; Ewings sarcoma; fetal hemoglobin; Fetal Hemoglobin - genetics; Fetal Hemoglobin - metabolism; Fetuses; gamma-Globins - genetics; gamma-Globins - metabolism; Gene Expression; Gene regulation; Genes; Genetic aspects; Genetic transcription; globin genes; Hemoglobin; Humans; Kruppel-Like Transcription Factors - genetics; Leukemia; Membranes; mithramycin; Oct-4 protein; Plicamycin - pharmacology; Promoters (Genetics); Proteins; Repressor Proteins - genetics; Repressors; Sickle cell anemia; Sickle cell disease; Thalassemia; Transcription; Transcription factors; Transcription Factors - genetics; Tumors; β-thalassemia; St Louis Missouri; United States > US; Italy; fetal hemoglobin; transcription; BCL11A; globin genes; mithramycin; β-thalassemia; HbF inducers
• ISSN: 2073-4425; 2073-4425
• DOI: 10.3390/genes14101927

The anticancer drug mithramycin (MTH), has been proposed for drug repurposing after the finding that it is a potent inducer of fetal hemoglobin (HbF) production in erythroid precursor cells (ErPCs) from β-thalassemia patients. In this respect, previously published studies indicate that MTH is very active in inducing increased expression of γ-globin genes in erythroid cells. This is clinically relevant, as it is firmly established that HbF induction is a valuable approach for the therapy of β-thalassemia and for ameliorating the clinical parameters of sickle-cell disease (SCD). Therefore, the identification of MTH biochemical/molecular targets is of great interest. This study is inspired by recent robust evidence indicating that the expression of γ-globin genes is controlled in adult erythroid cells by different transcriptional repressors, including Oct4, MYB, BCL11A, Sp1, KLF3 and others. Among these, BCL11A is very important. In the present paper we report evidence indicating that alterations of BCL11A gene expression and biological functions occur during MTH-mediated erythroid differentiation. Our study demonstrates that one of the mechanisms of action of MTH is a down-regulation of the transcription of the BCL11A gene, while a second mechanism of action is the inhibition of the molecular interactions between the BCL11A complex and specific sequences of the γ-globin gene promoter.